Tag: European Commission authorises fifth safe and effective vaccine against COVID-19
European Commission authorizes fifth safe and effective vaccine against COVID-19
European Commission authorises fifth safe and effective vaccine against COVID-19
Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine Nuvaxovid, developed by Novavax, the fifth COVID-19 vaccine authorised in...